ARKAYLI BIOPHARMA INC. RECEIVES STUDY MAY PROCEED RESPONSE TO IND FROM FDA AND SBIR GRANT FROM NIH TO ADVANCE CLINICAL DEVELOPMENT OF ARK001 FOR A RARE PEDIATRIC DISEASE

Reuters · 1d ago

Please log in to view news